Galmed Pharmaceuticals Ltd.
Symbol: GLMD (NASDAQ)
1.52
▼ (-2.26%) -0.035
Company Description:
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
Key Stats
- Today's Open: $1.55
- Today's High: $1.6
- Today's Low: $1.471
- Today's Volume: 59.37K
- Yesterday Close: $1.55
- Yesterday High: $1.55
- Yesterday Low: $1.41
- Yesterday Volume: 127.36K
- Last Min Volume: 5
- Last Min High: $1.515
- Last Min Low: $1.515
- Last Min VWAP: $1.515
Company Profile
- Name: Galmed Pharmaceuticals Ltd.
- Website: https://www.galmedpharma.com
- Listed Date: 2014-03-13
- Location: ,
- Market Status: Active
- CIK Number: 0001595353
- SIC Code:
- SIC description:
- Market Cap: $7.73M
- Round Lot: 100
- Outstanding Shares: 5.48M
- Asset Type: CS
RECENT FILINGS FOR GLMD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-02 | EFFECT | View |
| 2025-09-02 | EFFECT | View |
| 2025-08-28 | POS AM | View |
| 2025-08-28 | POS AM | View |
| 2025-08-28 | 6-K | View |
| 2025-08-25 | 6-K | View |
| 2025-08-21 | EFFECT | View |
| 2025-08-21 | 424B3 | View |
| 2025-08-18 | F-1 | View |
| 2025-08-15 | 6-K | View |
| 2025-08-14 | 6-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-07-24 | 6-K | View |
| 2025-05-27 | 6-K | View |
| 2025-05-22 | 6-K | View |
| 2025-05-13 | 6-K | View |
| 2025-05-06 | 6-K | View |
| 2025-04-28 | 6-K | View |
| 2025-04-17 | 6-K | View |
| 2025-04-15 | 6-K | View |
Latest News on GLMD